Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation.
Zimetbaum
Peter
P
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Clinical Research Institute, Boston, Massachusetts 02215, USA. pzimetba@caregroup.harvard.edu
Ho
Kalon K L
KK
Olshansky
Brian
B
Hadjis
Thomas
T
Lemery
Robert
R
Friedman
Paul A
PA
Cannom
David S
DS
Chen
Xiao Hua
XH
Josephson
Mark E
ME
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002170:Canada; D017723:Drug Utilization Review; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011446:Prospective Studies; D012042:Registries; D014481:United States
D000889:Anti-Arrhythmia Agents